How accurately do we measure blood glucose levels in intensive care unit (ICU) patients?

Best Practice and Research: Clinical Anaesthesiology

Volumn 23, Issue 4, 2009, Pages 387-400

  Wahl, Hans Günther ^a,b  

^a Medizinisches Labor Wahl   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

assay principles; critically ill patients; method evaluation; point of care testing (POCT) glucose meters; specimen matrices; tight glycaemic control

Indexed keywords

GLUCOSE; GLUCOSE DEHYDROGENASE; GLUCOSE OXIDASE; GLYCOGEN; HEXOKINASE; INSULIN;

ACCURACY; BLOOD GLUCOSE MONITORING; COLORIMETRY; COULOMETRY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; ENZYME ANALYSIS; FEEDBACK SYSTEM; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCOGENOLYSIS; HUMAN; HYPERGLYCEMIA; INFRARED SPECTROSCOPY; INSULIN TREATMENT; INTENSIVE CARE UNIT; MASS SPECTROMETRY; MORBIDITY; MORTALITY; PHOTOMETRY; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SELF EVALUATION; TREATMENT OUTCOME;

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; POINT-OF-CARE SYSTEMS;

EID: 70849119720     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2009.09.003     Document Type: Review

References (99)

1. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine 345 (2001) 1359-1367
2. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354 (2006) 449-461
3. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in servere sepsis. The New England Journal of Medicine 358 (2008) 125-139
4. Arabi Y.M., Dabbagh O.C., Tamim H.M., et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Critical Care Medicine 36 (2008) 3190-3197
5. De La Rosa G.D.C., Donado J.H., Restrepo A.H., et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care 12 (2008) R120
6. Devos P., Preiser J., and Mélot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. [abstract]. Intensive Care Medicine 33 (2007) S189
7. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 31 Suppl. 1 (2008) S12-S54
8. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice 13 Suppl. 1 (2007) 1-68
9. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine 36 (2008) 296-327
10. Wiener R.S., Wiener D.C., and Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300 8 (2008) 933-944
11. Griesdale D.E., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal 180 8 (2009) 821-827
12. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. The New England Journal Of Medicine 360 (2009) 1283-1297
13. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 (2006) 3151-3159
14. Kanji S., Singh A., Tierney M., et al. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Medicine 30 (2004) 804-810
15. Hirshberg E., Lacroix J., Sward K., et al. Blood glucose control in critically ill adults and children. Chest 133 6 (2008) 1328-1335
16. Merz T.M., and Finfer S. Pro/con debate: is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients?. Critical Care 12 2 (2008) 212
17. Brunkhorst F.M., and Wahl H.G. Blood glucose measurements in the critically ill: more than just a blood draw. Critical Care 10 6 (2006) 178
18. Mahoney J., and Ellison J. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Clinical Chemistry 53 (2007) 1122-1128
19. Dungan K., Chapman J., Braithwaite S.S., and Buse J. Glucose measurements: confounding issues in setting targets for inpatient management. Diabetes Care 30 (2007) 403-409
20. Scott M.G., Bruns D.E., Boyd J.C., et al. Tight glucose control in the intensive care unit: are glucose meters up to the task?. Clinical Chemistry 55 (2009) 18-20
21. Boyd J.C., and Bruns D.E. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clinical Chemistry 47 (2001) 209-214
22. Price C. Point-of-care testing in diabetes mellitus. Clinical chemistry and laboratory medicine 41 (2003) 1213-1219
23. Wahl H.G., Koschinsky T., and Schlebusch H. Glukosebestimmung. In: Luppa P.B., and Schlebusch H. (Eds). POCT - Patientennahe Labordiagnostik. 1st edn. (2008), Springer, Berlin Heidelberg 55-66
24. Hannestad U., and Lundblad A. Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood. Clinical Chemistry 43 (1997) 794-800
25. Wiener K. Whole blood glucose: what are we actually measuring?. Annals of Clinical Biochemistry 32 (1995) 1-8
26. Burnett R.W., D'Orazio P., Fogh-Andersen N., et al. Scientific Division, Working Group on Selective Electrodes: IFCC recommendation on reporting results for blood glucose. Clinica Chimica Acta 307 (2001) 205-209
27. Jørgensen L.G., Brandslund I., Petersen P.H., et al. The effect of the new ADA and WHO guidelines on the number of diagnosed cases of diabetes mellitus. Clinical Chemistry and Laboratory Medicine 41 9 (2003) 1246-1250
28. Bürgi W. The volume displacement effect in quantitative analyses in red cell constituents. Zeitschrift Für Klinische Chemie Und Klinische Biochemie 7 (1969) 458-460
29. D'Orazio P., Burnett R.W., Fogh-Andersen N., et al. The International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing: approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clinical Chemistry 51 (2005) 1573-1576
30. Rainey P.M., and Jatlow P. Monitoring blood glucose meters. American Journal of Clinical Pathology 103 (1995) 125-126
31. Fogh-Andersen N., Wimberley P.D., Thode J., and Siggard-Andersen O. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. Clinica Chimica Acta 189 (1990) 33-38
32. Savoca R., Jaworek B., and Huber A.R. New "plasma referenced" POCT glucose monitoring systems-are they suitable for glucose monitoring and diagnosis of diabetes?. Clinica Chimica Acta 372 1-2 (2006) 199-201
33. Lacara T., Domagtoy C., Lickliter D., et al. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. American Journal of Critical Care 16 4 (2007) 336-346
34. Fogh-Andersen N., and D'Orazio P. Proposal for standardizing direct- reading biosensors for blood glucose. Clinical Chemistry 44 (1998) 655-659
35. Steffes M.W., and Sacks D.B. Measurement of circulating glucose concentrations: the time is now for consistency among methods and types of samples. Clinical Chemistry 51 9 (2005) 1569-1570
36. Tang Z., Lee J.H., Louie R.F., and Kost G.J. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Archives of Pathology & Laboratory Medicine 124 (2000) 1135-1140
37. Wiener K. An assessment of the effect of haematocrit on the HemoCue blood glucose analyser. Annals Of Clinical Biochemistry 30 (1993) 90-93
38. Patrick L., Lynch M., and O'Kane M.J. Methemoglobin interferes with the HemoCue B-Glucose Analyzer. Clinical Chemistry 48 (2002) 581-583
39. Tang Z., Louie R.F., Payes M., et al. Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technology & Therapeutics 2 (2000) 349-362
40. Kurahashi K., Maruta H., Usuda Y., and Ohtsuka M. Influence of blood sample oxygen tension on blood glucose concentration measured using an enzyme-electrode method. Critical Care Medicine 25 (1997) 231-235
41. Kost G.J., Vu H.T., Inn M., et al. Multicenter study of whole-blood creatinine, total carbon dioxide content, and chemistry profiling for laboratory and point-of-care testing in critical care in the United States. Critical Care Medicine 28 (2000) 2379-2389
42. Tang Z., Du X., Loie R.F., et al. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. American Journal Of Clinical Pathology 113 (2000) 75-86
43. Kost G.J., Nguyen T.H., and Tang Z. Wholeblood glucose and lactate: trilayer biosensors, drug interference, metabolism, and practice guidelines. Archives Of Pathology & Laboratory Medicine 124 (2000) 1128-1134
44. Janssen W., Harff G., Caers M., and Schellekens A. Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clinical Chemistry 44 (1998) 2379-2380
45. Ashworth L., Gibb I., and Alberti K.G. Hemo Cue: evaluation of a portable photometric system for determining glucose in whole blood. Clinical Chemistry 38 (1992) 1479-1482
46. Rao L.V., Jakubiak F., Sidwell J.S., et al. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clinica chimica acta 356 1-2 (2005) 178-183
47. Marks V. Blood glucose: its measurement and clinical importance. Clinica Chimica Acta 251 (1996) 3-17
48. Burrin J.M., and Alberti K.G. What is blood glucose: can it be measured?. Diabetic Medicine 7 (1990) 199-206
49. Tang Z., Louie R.F., Lee J.H., et al. Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Critical Care Medicine 29 (2001) 1062-1070
50. Tang Z., Du X., Louie R.F., and Kost G.J. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Archives Pathology Laboratory Medicine 124 (2000) 577-582
51. Karon B.S., Griesmann L., Scott R., et al. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technology & Therapeutics 10 2 (2008) 111-120
52. Bellini C., Serra G., Risso D., et al. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit. Clinical Chemistry and Laboratory Medicine 45 11 (2007) 1549-1554
53. Sharief N., and Hussein K. Comparison of two methods of measurement of whole blood glucose in the neonatal period. Acta Paediatrica 86 11 (1997) 1246-1252
54. Chan P.C., Rozmanc M., Seiden-Long I., and Kwan J. Evaluation of a point-of-care glucose meter for general use in complex tertiary care facilities. Clinical Biochemistry 42 10-11 (2009) 1104-1112
55. Slater-MacLean L., Cembrowski G., Chin D., et al. Accuracy of glycemic measurements in the critically ill. Diabetes Technology & Therapeutics 10 (2008) 169-177
56. Ghys T., Goedhuys W., Spincemaille K., et al. Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters. Clinica Chimica Acta 386 1-2 (2007) 63-68
57. Karon B.S., Gandhi G.Y., Nuttall G.A., et al. Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. American Journal Of Clinical Pathology 127 6 (2007) 919-926
58. Harrison J.G. Accuracy of fingerstick glucose values in shock patients. American Journal of Critical Care 4 (1995) 44-48
59. Kulkarni A., Saxena M., Price G., et al. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Medicine 31 (2005) 142-145
60. Kuwa K., Nakayama T., Hoshino T., and Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clinica Chimica Acta 307 (2001) 187-192
61. Finkielmann J.D., Oyen L.J., and Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest 127 (2005) 1749-1751
62. Cartier L.J., Leclerc P., Pouliot M., et al. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-Chek Advantage glucose meters. Clinical Chemistry 44 (1998) 893-894
63. U.S. Food and Drug Administration. Important Safety Information on Interference With Blood Glucose Measurement Following Use of Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products (2009). http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm154213.h tm Checked July 14th
64. Nobels F., Beckers F., Bailleul E., et al. Feasibility of a quality assurance programme of bedside blood glucose testing in a hospital setting: 7 years experience. Diabetic Medicine 21 (2004) 1288-1291
65. Kavasak P.A., Zielinski N., Li D., et al. Challenges of implementing point-of-care testing (POCT) glucose meters in a pediatric acute care setting. Clinical Biochemistry 37 (2004) 811-817
66. Baum J.M., Monhaut N.M., Parker D.R., and Price C.P. Improving the quality of self-monitoring blood glucose measurement: a study in reducing calibration errors. Diabetes Technology Therapeutics 8 3 (2006) 347-357
67. Boyd R., Leigh B., and Stuart P. Capillary versus venous bedside blood glucose estimations. Emergency Medicine Journal 22 (2003) 177-179
68. Corstjens A.M., Ligtenberg J.J.M., Van der horst I.C.C., et al. Accuracy and feasibility of point-of-care and continuous blood glucose analyzing in critically ill ICU patients. Critical Care 10 (2006) R135
69. Yamashita K., Okabayashi T., Yokoyama T., et al. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiologica Scandinavica 53 1 (2009) 66-71
70. Yamashita K., Okabayashi T., Yokoyama T., et al. The accuracy of a continuous blood glucose monitor during surgery. Anesthesia and Analgesia 106 1 (2008) 160-163
71. Opitz D. Patientennahe Sofortdiagnostik und Glykolyseinhibition in der Blutglukoseanalytik. INAUGURAL-DISSERTATION zur Erlangung des Doktorgrades der gesamten Medizin dem Fachbereich Medizin der Philipps-Universität Marburg 2007. http://archiv.ub.uni-marburg.de/diss/z2007/0378/pdf/ddo.pdfGlykolyse Checked July 14th 2009
72. Vesper H.W., Archibold E., and Myers G.L. Assessment of trueness of glucose measurement instruments with different specimen matrices. Clinica Chimica Acta 358 1-2 (2005) 68-74
73. Arabadjief D., and Nicholas J.H. Assessing glucose meter accuracy. Current Medical Research and Opinion 22 11 (2006) 2167-2174
74. Khan A.I., Vasquez Y., Gray J., et al. The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Archives of Pathology & Laboratory Medicine 130 10 (2006) 1527-1532
75. NCCLS. Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline - second edition. NCCLS document C30-A2 (2002), NCCLS. 1-56238-471-6
76. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clinical Chemistry 49 (2003) 7-18
77. Wehmeier M., Arndt B.T., Schumann G., and Külpmann W.R. Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices. Clinical Chemistry Laboratory Medicine 44 (2006) 888-893
78. Chen E.T., Nichols J.H., Duh S.H., and Hortin G. Performance evaluation of blood glucose monitoring devices. Diabetes Technology & Therapeutics 5 (2003) 749-768
79. Mahoney J.J., and Ellison J.M. Assessing glucose monitor performance-a standardized approach. Diabetes Technology & Therapeutics 9 6 (2007) 545-552
80. Slingerland R.J., and Miedema K. Evaluation of portable glucose meters. Problems and recommendations. Clinical Chemistry and Laboratory Medicine 41 (2003) 1220-1223
81. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings 79 (2004) 992-1000
82. Goldberg P.A., Siegel M.D., Sherwin R., et al. Implementation of a safe and effective insulin infusion protocol in medical intensive care unit. Diabetes Care 27 (2004) 461-467
83. Volgelzang M., and Ligtenberg J.J. Practical aspects of implementing tight glucose control in the ICU. Current Opinion in Clinical Nutrition and Metabolic Care 10 (2007) 178-180
84. Skyler J.S. Continuous glucose monitoring: an overview of its development. Diabetes Technology & Therapeutics 11 (2009) S5
85. Mastrototaro J.J. The MiniMed continuous glucose monitoring system. Diabetes Technology & Therapeutics 2 (2000) S13-S18
86. Hovorka R. The future of continuous glucose monitoring: closed loop. Current Diabetes Reviews 4 3 (2008) 269-279
87. De Block C., Manuel-y-Keenoy B., Rogiers P., et al. Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Current Diabetes Reviews 4 3 (2008) 234-244
88. Battelino T., and Bolinder J. Clinical use of real-time continuous glucose monitoring. Current Diabetes Reviews 4 3 (2008) 218-222
89. Wentholt I.M., Hart A.A., Hoekstra J.B., and DeVries J.H. Evaluating clinical accuracy of continuous glucose monitoring devices: other methods. Current Diabetes Reviews 4 3 (2008) 200-206
90. Clarke W.L., Anderson S., and Kovatchev B. Evaluating clinical accuracy of continuous glucose monitoring systems: Continuous Glucose-Error Grid Analysis (CG-EGA). Current Diabetes Reviews 4 3 (2008) 193-199
91. Sparacino G., Facchinetti A., Maran A., and Cobelli C. Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems. Current Diabetes Reviews 4 3 (2008) 181-192
92. Reach G., and Choleau C. Continuous glucose monitoring: physiological and technological challenges. Current Diabetes Reviews 4 3 (2008) 175-180
93. Hirsch I.B., Armstrong D., Bergenstal R.M., et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technology & Therapeutics 10 4 (2008) 232-244
94. Lodwig V., and Heinemann L. Glucose Monitoring Study Group: continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technology & Therapeutics 5 (2003) 572-586
95. Diabetes Research in Children Network (DirecNet) Study Group. The Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System in children with Type 1 Diabetes. Diabetes Care 30 (2007) 59-64
96. Csoregi E., Schmidtke D.W., and Heller A. Design and optimization of a selective subcutaneously implantable glucose electrode based on ''wired'' glucose oxidase. Analytical Chemistry 67 (1995) 1240-1244
97. Albisser A.M., Leibel B.S., Ewart T.G., et al. An artificial endocrine pancreas. Diabetes 23 (1974) 389-396
98. Fogt E.J., Dodd L.M., Jenning E.M., and Clemens A.H. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system (Biostator). Clinical Chemistry 24 (1978) 1366-1372
99. Hiramatsu S., Sako Y., Mimura K., et al. Impaired feedback inhibition of insulin secretion by hyperinsulinemia in patients with insulinoma. Endocrine Journal 42 (1995) 39-42